OPC-108459
- Generic Name
- OPC-108459
A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02069119
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
Phase 1
Terminated
- Conditions
- Atrial FibrillationParoxysmal Atrial FibrillationPersistent Atrial Fibrillation
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2017-04-10
- Target Recruit Count
- 40
- Registration Number
- NCT01483183
- Locations
- 🇬🇧
Otsuka Investigational Site, Chertsey, Surrey, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath